Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q112988778)
Watch
English
CYP19A1 binds Aromatase inhibitors
An instance of the biological reaction in Homo sapiens with Reactome ID (R-HSA-9707353)
In more languages
edit
Statements
instance of
biological process
1 reference
stated in
Reactome
retrieved
8 July 2022
Reactome ID
R-HSA-9707353
part of
Estrogen biosynthesis
1 reference
stated in
Reactome
retrieved
8 July 2022
Reactome ID
R-HSA-9707353
found in taxon
Homo sapiens
1 reference
stated in
Reactome
retrieved
8 July 2022
Reactome ID
R-HSA-9707353
exact match
https://identifiers.org/reactome:R-HSA-9707353
1 reference
stated in
Reactome
retrieved
8 July 2022
Reactome ID
R-HSA-9707353
has part(s)
Aromatase inhibitors [cytosol]
quantity
1
object has role
reactant
1 reference
stated in
Reactome
retrieved
8 July 2022
Reactome ID
R-HSA-9707353
cytochrome P450 family 19 subfamily A member 1
quantity
1
object has role
reactant
1 reference
stated in
Reactome
retrieved
8 July 2022
Reactome ID
R-HSA-9707353
CYP19A1:Aromatase inhibitors [endoplasmic reticulum membrane]
quantity
1
object has role
product
1 reference
stated in
Reactome
retrieved
8 July 2022
Reactome ID
R-HSA-9707353
cites work
Fadrozole hydrochloride: a potent, selective, nonsteroidal inhibitor of aromatase for the treatment of estrogen-dependent disease
1 reference
stated in
Reactome
retrieved
8 July 2022
Reactome ID
R-HSA-9707353
HPMA copolymer-aminoglutethimide conjugates inhibit aromatase in MCF-7 cell lines
1 reference
stated in
Reactome
retrieved
8 July 2022
Reactome ID
R-HSA-9707353
An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane
1 reference
stated in
Reactome
retrieved
8 July 2022
Reactome ID
R-HSA-9707353
Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor
1 reference
stated in
Reactome
retrieved
8 July 2022
Reactome ID
R-HSA-9707353
Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo
1 reference
stated in
Reactome
retrieved
8 July 2022
Reactome ID
R-HSA-9707353
Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer
1 reference
stated in
Reactome
retrieved
8 July 2022
Reactome ID
R-HSA-9707353
Identifiers
Reactome ID
R-HSA-9707353
1 reference
stated in
Reactome
retrieved
8 July 2022
Reactome ID
R-HSA-9707353
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit